이점
Certara played a pivotal role in helping the Xentria team determine optimal dosing strategies for XTMAB-16. These insights provided invaluable guidance for Xentria’s clinical development efforts for this product in a rare indication.
Certara’s comprehensive support, from dose optimization through advanced modeling to expert medical writing assistance, empowers pharmaceutical companies like Xentria to advance their research, make informed drug development decisions, and share their research findings with the scientific community.